[{"data":1,"prerenderedAt":268},["ShallowReactive",2],{"story-20765-tw":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":47,"questions":48,"relatedArticles":58,"body_color":266,"card_color":267},"20765",null,"Biotech M&A Wave: $30B Deal Signals Global Health Innovation","- Strategic Acquisition Impacts 50+ Healthcare & E-Commerce Supply Chains",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,17,23,24,25,26,27,28,29,30,31,32,33,34,35,19,36,29,37,38,10,39,40,41,42,43,13,44,45,46],"https://news.stocktwits-cdn.com/large_Getty_Images_2197271762_jpg_e7153010f5.webp","https://www.statnews.com/wp-content/uploads/2015/11/PHARMALOT_LITTLE-copy-645x645.jpg","https://static.asianetnews.com/images/w-1280,h-720,format-webp,imgid-external,imgname-image-db9ad719-3a7e-4d51-b30a-12e57e31c303.webp","https://images.barrons.com/im-252323?width=700&height=466","https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDhVYmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f92b80ab990022a4e039c50e71d01544aea0cd54/905.jpg?locale=de","https://static.biospace.com/dims4/default/665d60f/2147483647/strip/true/crop/1254x706+0+65/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2F6d%2Fcb%2F98115fa04814b325b5506f1ac675%2Fistock-2161981967.jpg","https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e","https://images.wsj.net/im-89530515?width=700&height=466","https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg","https://images.barrons.com/im-77034?width=700&height=466","https://eu-images.contentstack.com/v3/assets/blt72fb3b8b4630b7db/blt7f44a675a3ef8a74/6961090affc87a6baee2ee35/Depositphotos_162484262_L.jpg?width=1280&auto=webp&quality=80&format=jpg&disable=upscale","https://staticx-tuner.zacks.com/images/articles/charts/80/140639.jpg?v=1259431275","https://c.firstwordpharma.com/firstwordgroup/assets/adobe/images/money_chalkboard_bulb_dollarsigns.jpeg","https://plib.aastocks.com/aafnnews/image/medialib/20220919110401620_m.jpg","https://s.tradingview.com/static/images/illustrations/news-story.jpg","https://ts2.tech/wp-content/uploads/2026/01/revolution-medicines-rvmd-stock-slips-in-premarket-as-abbvie-denies-takeover-talks-deal-buzz-lingers-featured-2.jpg","https://medicaldialogues.in/h-upload/2024/02/03/1500x900_231498-merck-50.webp","https://marketminute.ghost.io/content/images/size/w1200/2026/01/d7bcc50d-ffad-49ed-87a4-81f81b7803e1.png","https://pharmaphorum.com/sites/default/files/styles/x_large/public/2026-01/ash-amplifies-spinning-top-unsplash-1200x675.jpg?itok=dOJsLR8N","https://static.gurufocus.com/logos/0C000008C5.png?20","https://static.asianetnews.com/images/w-1280,h-720,format-webp,imgid-external,imgname-image-4c0963cf-8023-499a-8ee2-cbe965d97383.webp","https://media.zenfs.com/en/reuters.com/9864f423d03771cceaa5732217377e7e","https://staticx-tuner.zacks.com/images/articles/charts/e4/140881.jpg?v=1496839690","https://images.ft.com/v3/image/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F35607cf6-a807-4227-9b69-c1a97bf6752f.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1","https://content.stockstotrade.com/wp-content/uploads/2026/01/biotech-stock-market-surge-2.png","https://www.reuters.com/resizer/v2/DIHH4543ZVJZRKKIM7EXD3KF2Y.jpg?auth=6abdf15d981313e029e71a6d81e9f921da7f4fd4f276e875114b4ab4a820a78d&width=1920&quality=80","https://s3.amazonaws.com/wp-uploads-trefis/articles/wp-content/uploads/2025/10/27050429/why_stock_moved_down-300x300.png","https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2021/10/26121101/myriam-zilles-KltoLK6Mk-g-unsplash-768x474.jpg","https://ts2.tech/wp-content/uploads/2026/01/abbvie-stock-drops-before-the-bell-after-revolution-medicines-deal-talk-gets-swatted-down-featured.jpg","https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2248270095/image_2248270095.jpg?io=getty-c-w1280","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ip39hDnFsPGs/v1/1200x799.jpg","https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1210931291/image_1210931291.jpg?io=getty-c-w630","https://imgproxy.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/18904062/3l0mq/ALTERNATES/master-3_2/usa-vaccineshpv","https://endpoints.news/wp-content/uploads/2025/06/Merck-shutterstock-social21.jpg","https://www.marketbeat.com/logos/revolution-medicines-inc-logo-1200x675.png?v=20221123154457","https://content.timothysykes.com/cdn-cgi/image/quality=90,format=webp,width=740/https://content.timothysykes.com/wp-content/uploads/2026/01/revolution-medicines-stock-soars-sacquisition-talks-spark-investor-interests.png","The potential $30 billion acquisition of Revolution Medicines by Merck represents a pivotal moment in pharmaceutical innovation with profound cross-border e-commerce implications. **This landmark transaction signals a strategic consolidation trend** that will reshape healthcare product supply chains and create emerging opportunities for digital sellers specializing in medical technologies, wellness products, and precision health solutions.\n\n**Key strategic implications emerge for cross-border sellers:** The deal highlights the increasing value of specialized, targeted medical research platforms. Revolution's experimental drug targeting RAS gene mutations demonstrates how niche biotechnology capabilities can command substantial market valuations. For e-commerce sellers, this signals a critical opportunity to develop specialized product lines targeting precision medicine markets.\n\nThe acquisition follows Merck's aggressive pipeline expansion strategy, which has nearly tripled its late-stage development portfolio since 2021. This trend suggests growing demand for sophisticated healthcare products that can be efficiently distributed through digital platforms. E-commerce sellers should anticipate increased interest in:\n- Personalized health supplements\n- Diagnostic testing kits\n- Targeted wellness technologies\n- Precision nutrition products\n\nSellers positioned in health technology, wellness, and medical supply categories can leverage this trend by:\n1. Developing product lines aligned with precision medicine concepts\n2. Investing in research-backed health product development\n3. Creating marketing narratives emphasizing scientific innovation\n4. Exploring cross-border markets with advanced healthcare ecosystems",[49,52,55],{"title":50,"answer":51,"author":5,"avatar":5,"time":5},"What strategic moves should e-commerce sellers consider?","Sellers should invest in research-driven product development, create compelling scientific marketing narratives, explore cross-border healthcare markets, and develop product lines that align with precision medicine trends emerging from advanced biotechnology research.",{"title":53,"answer":54,"author":5,"avatar":5,"time":5},"How might this Merck acquisition impact cross-border e-commerce sellers?","The acquisition signals growing demand for specialized health products. Sellers should develop targeted product lines in precision medicine, wellness technologies, and scientifically-validated health supplements. The $30B deal indicates significant market potential for innovative healthcare e-commerce offerings.",{"title":56,"answer":57,"author":5,"avatar":5,"time":5},"What product categories could benefit from this biotech merger?","Promising categories include personalized diagnostic kits, targeted nutrition supplements, advanced wellness technologies, and research-backed health products. Sellers focusing on scientifically-validated, precision health solutions are likely to see increased market opportunities.",[59,64,68,72,77,81,85,89,93,97,101,105,109,112,116,120,124,129,133,137,141,145,149,153,157,161,165,168,172,176,180,184,188,192,196,200,203,206,210,213,217,221,225,228,232,235,239,243,247,251,255,259,263],{"id":60,"title":61,"source":62,"logo":5,"time":63},205559,"Price tag of $28bn to $32bn was being discussed as part of Merck-Revolution Medicines deal - FT","https://www.marketscreener.com/news/price-tag-of-28bn-to-32bn-was-being-discussed-as-part-of-merck-revolution-medicines-deal-ft-ce7e59ddd089fe23","4天前",{"id":65,"title":66,"source":67,"logo":29,"time":63},205558,"Merck (MRK) Engages in Discussions with Competitor Firm","https://www.gurufocus.com/news/4102963/merck-mrk-engages-in-discussions-with-competitor-firm",{"id":69,"title":70,"source":71,"logo":42,"time":63},205557,"Revolution Medicines soars on report Merck in talks to buy (update) (RVMD:NASDAQ)","https://seekingalpha.com/news/4537873-revolution-medicines-soars-on-report-merck-in-talks-to-buy",{"id":73,"title":74,"source":75,"logo":37,"time":76},205567,"Revolution Medicines (RVMD) Hits All-Time High on Buyout Buzz; Buyer Denies Talks","https://finviz.com/news/270150/revolution-medicines-rvmd-hits-all-time-high-on-buyout-buzz-buyer-denies-talks","5天前",{"id":78,"title":79,"source":80,"logo":13,"time":76},205566,"AbbVie, Revolution Medicines Stocks Fall After Drugmaker Denies Takeover Report","https://www.barrons.com/articles/abbvie-stock-revolution-medicines-deal-60137788?gaa_at=eafs&gaa_n=AWEtsqepiNwJ0qxGfBG7JK63TJCv2rGtTW3RLuFDzL9L-PHBO-9oiCA4O4eW&gaa_ts=696165a3&gaa_sig=XhZmlRPl0HOIhaxjxfuvD1QDRUk3aTbriJJijLadyFZZYZWIiLmBdWtsUZc5md3e2BBHYuaLZCwxwaXIZRIPug%3D%3D",{"id":82,"title":83,"source":84,"logo":27,"time":76},205565,"The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader","https://markets.financialcontent.com/stocks/article/marketminute-2026-1-8-the-20-billion-question-revolution-medicines-surges-as-big-pharma-circles-the-pan-ras-leader",{"id":86,"title":87,"source":88,"logo":36,"time":76},205564,"Revolution Medicines Stock Pre-Market (-6.0%): AbbVie Denies Acquisition Talks","https://www.trefis.com/data/companies/RVMD/no-login-required/NY492CU4/Revolution-Medicines-Stock-Pre-Market-6-0-AbbVie-Denies-Acquisition-Talks",{"id":90,"title":91,"source":92,"logo":45,"time":76},205563,"Revolution Medicines (NASDAQ:RVMD) Shares Gap Down - Time to Sell?","https://www.marketbeat.com/instant-alerts/revolution-medicines-nasdaqrvmd-shares-gap-down-time-to-sell-2026-01-08/",{"id":94,"title":95,"source":96,"logo":10,"time":76},205562,"Merck Looks To Buy Cancer Drugmaker Revolution Medicines As Keytruda Nears Patent Expiry: Report","https://stocktwits.com/news-articles/markets/equity/merck-looks-to-buy-cancer-drugmaker-revolution-medicines-report/cmUbkVCR450",{"id":98,"title":99,"source":100,"logo":5,"time":76},205561,"Crypto: RVMDW's Explosive Surge: Where Is It Heading Next?","https://www.interactivecrypto.com/rvmdw-s-explosive-surge-where-is-it-heading-next",{"id":102,"title":103,"source":104,"logo":5,"time":76},205560,"US Stock Movement | Revolution Medicines Surges Over 13% in After-Hours Trading Amid Reports of Acquisition Talks with Merck for Up to $32 Billion","https://www.bitget.com/news/detail/12560605138086",{"id":106,"title":107,"source":108,"logo":41,"time":76},205569,"RVMD Stock Hits a Record High on Rumored Takeover Interest","https://finance.yahoo.com/news/rvmd-stock-hits-record-high-141100306.html",{"id":110,"title":107,"source":111,"logo":21,"time":76},205568,"https://www.primepublishers.com/rvmd-stock-hits-a-record-high-on-rumored-takeover-interest/article_4eabe4e6-a3fd-5585-8260-cc03cf4f7425.html",{"id":113,"title":114,"source":115,"logo":5,"time":76},205570,"Stifel reiterates Buy rating on Revolution stock amid acquisition rumors By Investing.com","https://in.investing.com/news/analyst-ratings/stifel-reiterates-buy-rating-on-revolution-stock-amid-acquisition-rumors-93CH-5178766",{"id":117,"title":118,"source":119,"logo":28,"time":63},205539,"Report says MSD is in talks to buy Revolution Meds","https://pharmaphorum.com/news/report-says-msd-talks-buy-revolution-meds",{"id":121,"title":122,"source":123,"logo":5,"time":63},205538,"M&A News: Revolution Medicines (RVMD) Stock Rallies on News of Potential Acquisition by Merck","https://www.tipranks.com/news/ma-news-revolution-medicines-rvmd-stock-rallies-on-news-of-potential-acquisition-by-merck",{"id":125,"title":126,"source":127,"logo":34,"time":128},206477,"Revolution Medicines Soars Amid AbbVie Acquisition Talks","https://stockstotrade.com/news/revolution-medicines-inc-ordinary-shares-rvmd-news-2026_01_09/","3天前",{"id":130,"title":131,"source":132,"logo":40,"time":63},205537,"Merck in Talks to Buy Biotech Revolution Medicines, FT Says","https://www.bloomberg.com/news/articles/2026-01-08/merck-in-deal-talks-with-biotech-revolution-medicines-ft-says",{"id":134,"title":135,"source":136,"logo":12,"time":128},206478,"RVMD Stock Soars 11% After Reports Of Near $30B Buyout Talks With Merck","https://newsable.asianetnews.com/markets/rvmd-stock-soars-11-after-reports-of-near-30b-buyout-talks-with-merck-articleshow-f7gkhk0",{"id":138,"title":139,"source":140,"logo":44,"time":63},205536,"Speculation builds about a multibillion-dollar takeout of Revolution Medicines","https://endpoints.news/speculation-builds-about-a-deal-for-revolution-medicines/",{"id":142,"title":143,"source":144,"logo":29,"time":63},206479,"Merck (MRK) Eyes Acquisition of Revolution Medicines (RVMD) for $30 Billion","https://www.gurufocus.com/news/4104612/merck-mrk-eyes-acquisition-of-revolution-medicines-rvmd-for-30-billion",{"id":146,"title":147,"source":148,"logo":22,"time":63},205535,"Revolution Medicines takeout speculation spotlight shines on Merck & Co.","https://firstwordpharma.com/story/7049289",{"id":150,"title":151,"source":152,"logo":32,"time":63},205545,"Merck in Talks to Buy Revolution Medicines Per Financial Times Report","https://www.nasdaq.com/articles/merck-talks-buy-revolution-medicines-financial-times-report",{"id":154,"title":155,"source":156,"logo":31,"time":76},205666,"Merck in talks to buy biotech Revolution Medicines, FT reports","https://finance.yahoo.com/news/merck-talks-buy-biotech-revolution-205828159.html",{"id":158,"title":159,"source":160,"logo":39,"time":63},205544,"Revolution Medicines: \"Strong Buy\" As Acquisition Prospects Continue To Circle (RVMD)","https://seekingalpha.com/article/4858444-revolution-medicines-strong-buy-as-acquisition-prospects-continue-to-circle",{"id":162,"title":163,"source":164,"logo":35,"time":63},205665,"Merck in talks to buy biotech Revolution in up to $32 billion deal, FT reports","https://www.reuters.com/business/healthcare-pharmaceuticals/merck-talks-buy-biotech-revolution-medicines-ft-reports-2026-01-08/",{"id":166,"title":151,"source":167,"logo":14,"time":63},205543,"https://www.sharewise.com/de/news_articles/Merck_in_Talks_to_Buy_Revolution_Medicines_Per_Financial_Times_Report_Zacks_20260109_1803",{"id":169,"title":170,"source":171,"logo":17,"time":63},205664,"Merck in Talks to Buy Revolution Medicines for Around $30 Billion","https://www.wsj.com/health/pharma/merck-in-talks-to-buy-revolution-medicines-for-around-30-billion-13f798a1?gaa_at=eafs&gaa_n=AWEtsqcSCi0wrJ2HMzLYg9hFtbsk7zsLXHtff9RjgMpyQ4B8ks12kzWdZeZh&gaa_ts=696165a3&gaa_sig=GLnN_iAhkfcLH_NooJmsAI9GnQpJKpRWatAyw50TobQf0frNY-9v7ohDQcSSgh7EuirwzYsi8Cr8Z53Xfn7M7A%3D%3D",{"id":173,"title":174,"source":175,"logo":26,"time":63},205542,"Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal","https://medicaldialogues.in/news/industry/pharma/merck-in-talks-to-acquire-revolution-medicines-in-usd-28-32-billion-oncology-deal-162328",{"id":177,"title":178,"source":179,"logo":20,"time":63},205541,"Merck reportedly in talks to buy Revolution in huge $28–32bn deal","https://www.bioxconomy.com/partnering/merck-reportedly-in-talks-to-buy-revolution-in-huge-28-32bn-deal",{"id":181,"title":182,"source":183,"logo":43,"time":63},205540,"MSD possibly nearing massive acquisition","https://medwatch.com/News/Pharma___Biotech/article18904459.ece",{"id":185,"title":186,"source":187,"logo":5,"time":63},206480,"Revolution Medicines down 15% in after-hours after AbbVie denies takeover talks","https://www.tipranks.com/news/the-fly/revolution-medicines-down-15-in-after-hours-after-abbvie-denies-takeover-talks-thefly",{"id":189,"title":190,"source":191,"logo":10,"time":63},206481,"Merck In Talks To Acquire Revolution Medicines For About $30B: Report","https://stocktwits.com/news-articles/markets/equity/merck-in-talks-to-acquire-revolution-medicines-for-about-30-billion-report/cmU2pTHR4dy",{"id":193,"title":194,"source":195,"logo":5,"time":63},206482,"Merck Reportedly in Talks to Acquire Revolution Medicines (RVMD)","https://www.gurufocus.com/news/4104584/merck-reportedly-in-talks-to-acquire-revolution-medicines-rvmd",{"id":197,"title":198,"source":199,"logo":24,"time":63},206483,"Key facts: Merck in talks to acquire Revolution Medicines; seeks data on child vaccines","https://www.tradingview.com/news/tradingview:38799e4a8a9d3:0-key-facts-merck-in-talks-to-acquire-revolution-medicines-seeks-data-on-child-vaccines/",{"id":201,"title":170,"source":202,"logo":17,"time":63},206484,"https://www.wsj.com/health/pharma/merck-in-talks-to-buy-revolution-medicines-for-around-30-billion-13f798a1?gaa_at=eafs&gaa_n=AWEtsqeAl_GfUE6sUalsDIInhmG7wZs8z7KD0N1Rl78evHhf9lteE7ZECbxE&gaa_ts=69619b44&gaa_sig=4hKgHWYG6Hht6amxKdK_Z-dEOqeR3oeKI3uUDv3qGVBoWb7ukfAkYMAQxgTOs3u7KL91RKa5GKV-Wcq-S1GgOg%3D%3D",{"id":204,"title":151,"source":205,"logo":16,"time":63},206485,"https://finance.yahoo.com/news/merck-talks-buy-revolution-medicines-170300973.html",{"id":207,"title":208,"source":209,"logo":19,"time":63},206486,"Revolution Medicines Stock Jumps. Takeover Buzz Grows, Another Suitor Emerges.","https://www.barrons.com/articles/revolution-medicines-stock-takeover-merck-abbvie-78d054a3?gaa_at=eafs&gaa_n=AWEtsqfo7ssa2oHSuUktfcYOrNojal-ZOailZtq3V_ydmnuy3gb54Uk9TMEl&gaa_ts=69619b44&gaa_sig=QaZDu4rELEUBqEnjLJ7FmolUVRLzDhJPGastN5kfIaTmtHLv5absVd4zYDfWjbAiiEvIjdNhi2yZZAcB9kvQWQ%3D%3D",{"id":211,"title":95,"source":212,"logo":30,"time":63},206487,"https://newsable.asianetnews.com/markets/merck-looks-to-buy-cancer-drugmaker-revolution-medicines-as-keytruda-nears-patent-expiry-report-articleshow-79vyk34",{"id":214,"title":215,"source":216,"logo":23,"time":63},205549,"Merck Reportedly In Talks to Buy Biotech Firm Revolution Medicines for Up to US$32B","http://www.aastocks.com/en/mobile/news.aspx?newsid=NOW.1494976&newstype=71&newssource=AAFN",{"id":218,"title":219,"source":220,"logo":38,"time":76},206488,"AbbVie stock drops before the bell after Revolution Medicines deal talk gets swatted down","https://ts2.tech/en/abbvie-stock-drops-before-the-bell-after-revolution-medicines-deal-talk-gets-swatted-down/",{"id":222,"title":223,"source":224,"logo":5,"time":63},205548,"After-Hours Biotech Gainers: RVMD Soars On Merck Deal Talks Reports, SXTC, KALV, SGMT Rally","https://www.rttnews.com/3608996/after-hours-biotech-gainers-rvmd-soars-on-merck-deal-talks-reports-sxtc-kalv-sgmt-rally.aspx",{"id":226,"title":79,"source":227,"logo":13,"time":76},206489,"https://www.barrons.com/articles/abbvie-stock-revolution-medicines-deal-60137788?gaa_at=eafs&gaa_n=AWEtsqec40P93-3IJYWcWzCFgRkd_JGZTUrYnc1u4MsxpP9O4SA51aPTNJA0&gaa_ts=69619b44&gaa_sig=oqSoeZ6QcRkPUuESzvcnisHwRVcjUt39-Ew6Fjfh9UQ_ajadIYXsuZSoX-WSJzNKRyV0KABNg2MFC80kbf4HEQ%3D%3D",{"id":229,"title":230,"source":231,"logo":5,"time":63},205547,"Revolution Medicines jumps on report AbbVie nears takeover","https://www.msn.com/en-us/money/other/revolution-medicines-jumps-on-report-abbvie-nears-takeover/ar-AA1TLeQ1",{"id":233,"title":151,"source":234,"logo":18,"time":63},205546,"https://www.zacks.com/stock/news/2815199/merck-in-talks-to-buy-revolution-medicines-per-financial-times-report",{"id":236,"title":237,"source":238,"logo":33,"time":76},205667,"Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn","https://www.ft.com/content/93b4e80d-724a-4384-9e39-f6ff9474373a",{"id":240,"title":241,"source":242,"logo":46,"time":63},205556,"Revolution Medicines Stock Soars: Time to Buy?","https://www.timothysykes.com/news/revolution-medicines-inc-ordinary-shares-rvmd-news-2026_01_08/",{"id":244,"title":245,"source":246,"logo":5,"time":63},205555,"After AbbVie denies WSJ report, FT says Merck in talks to buy Revolution Medicines","https://www.chicagobusiness.com/health-care/merck-talks-buy-revolution-medicines-ft",{"id":248,"title":249,"source":250,"logo":25,"time":76},205554,"Revolution Medicines (RVMD) stock slips in premarket as AbbVie denies takeover talks, deal buzz lingers","https://ts2.tech/en/revolution-medicines-rvmd-stock-slips-in-premarket-as-abbvie-denies-takeover-talks-deal-buzz-lingers/",{"id":252,"title":253,"source":254,"logo":15,"time":63},205553,"Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie","https://www.biospace.com/business/revolution-soars-amid-swirling-buyout-rumors-with-merck-abbvie",{"id":256,"title":257,"source":258,"logo":5,"time":63},205552,"Merck & Co is accelerating the expansion of its oncology pipeline and is reportedly planning to acquire a cutting-edge pharmaceutical company for $30 billion.","https://news.futunn.com/en/post/67187605/merck-co-is-accelerating-the-expansion-of-its-oncology-pipeline",{"id":260,"title":261,"source":262,"logo":11,"time":63},205551,"Pharmalittle: We're reading about a potential Merck purchase, a J&J pricing deal with Trump, and more","https://www.statnews.com/pharmalot/2026/01/09/lilly-zepbound-jnj-merck-biotech-pharma/",{"id":264,"title":208,"source":265,"logo":19,"time":63},205550,"https://www.barrons.com/articles/revolution-medicines-stock-takeover-merck-abbvie-78d054a3?gaa_at=eafs&gaa_n=AWEtsqc4WSbAWOAa54MZ1W6c7yMqDEKv4AlmDmGXmKLCYe5y3rcoAMNQG043&gaa_ts=696165a3&gaa_sig=GXCBtChoqM3m5c1M9X8uC8858gdAe_r42dcanIpzd7stAtRhvPxjAzpPnZMc4zXv9z2WGpOxyTCxnRkmewzWPQ%3D%3D","#3a95ecff","#3a95ec4d",1768357900790]